Hunan Warrant Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100004P73
CNY
46.80
-5.2 (-10.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
372.11
377.48
336.23
335.96
330.71
365.69
369.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
372.11
377.48
336.23
335.96
330.71
365.69
369.58
Raw Material Cost
147.61
161.69
130.81
145.56
133.85
148.24
139.56
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.02
0.00
0.00
0.00
Selling and Distribution Expenses
151.59
140.40
140.10
128.89
126.31
125.35
151.95
Other Expenses
2.14
4.57
2.43
5.53
3.16
3.30
2.94
Total Expenditure (Excl Depreciation)
320.59
347.81
295.17
329.78
291.80
306.58
320.87
Operating Profit (PBDIT) excl Other Income
51.5
29.700000000000003
41.1
6.2
38.9
59.1
48.7
Other Income
93.21
10.15
9.94
8.13
16.70
5.81
22.78
Operating Profit (PBDIT)
138.80
52.98
67.65
24.13
67.94
72.63
87.86
Interest
0.00
0.00
0.00
0.02
0.00
0.00
0.00
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
224.50
215.79
205.42
190.40
196.86
217.45
230.02
Depreciation
0.00
19.76
19.76
18.51
18.51
17.54
17.54
Profit Before Tax
138.80
33.22
47.89
5.59
49.43
55.08
70.32
Tax
5.78
3.81
9.29
-1.19
2.37
6.96
14.78
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
136.01
29.90
41.21
5.91
45.62
52.74
60.05
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
136.01
29.90
41.21
5.91
45.62
52.74
60.05
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.18
-5.03
-3.97
-6.48
-5.74
-5.91
-7.42
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
134.82
24.87
37.25
-0.58
39.87
46.83
52.63
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,992.12
1,841.29
1,852.85
1,803.41
1,881.92
1,836.30
1,783.56
Earnings per share (EPS)
1.04
0.23
0.31
0.04
0.35
0.4
0.46
Diluted Earnings per share
1.04
0.23
0.31
0.04
0.35
0.4
0.46
Operating Profit Margin (Excl OI)
12.25%
6.11%
11.29%
-0.75%
9.9%
13.47%
12.86%
Gross Profit Margin
37.3%
14.03%
20.12%
7.18%
20.54%
19.86%
23.77%
PAT Margin
36.55%
7.92%
12.26%
1.76%
13.79%
14.42%
16.25%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 12.52% vs -1.20% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 237.84% vs -3.62% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is -10.94% vs -23.35% in Sep 2024

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Hunan Warrant Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
372.11
0
372.11
Other Operating Income
0.00
0.00
0.00
Total Operating income
372.11
0
372.11
Raw Material Cost
147.61
0
147.61
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
151.59
0
151.59
Other Expenses
2.14
0.00
2.14
Total Expenditure (Excl Depreciation)
320.59
0
320.59
Operating Profit (PBDIT) excl Other Income
51.52
0.00
51.52
Other Income
93.21
0
93.21
Operating Profit (PBDIT)
138.80
0
138.80
Interest
0.00
0
0.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
224.50
0
224.50
Depreciation
0.00
0
0.00
Profit Before Tax
138.80
0
138.80
Tax
5.78
0
5.78
Provisions and contingencies
0
0
0.00
Profit After Tax
136.01
0
136.01
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
136.01
0
136.01
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.18
0
-1.18
Other related items
0.00
0.00
0.00
Consolidated Net Profit
134.82
0
134.82
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,992.12
0
1,992.12
Earnings per share (EPS)
1.04
0
1.04
Diluted Earnings per share
1.04
0
1.04
Operating Profit Margin (Excl OI)
12.25%
0%
0.00
12.25%
Gross Profit Margin
37.30%
0%
0.00
37.30%
PAT Margin
36.55%
0%
0.00
36.55%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 37.21 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is -1.43% vs 12.28% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 12.52% vs -1.20% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 13.48 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 441.37% vs -33.06% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 237.84% vs -3.62% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.56 Million
in Sep 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Sep 2025 is 6.54% vs -25.82% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -10.94% vs -23.35% in Sep 2024

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.25%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024